SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001274644-17-000023
Filing Date
2017-03-30
Accepted
2017-03-30 17:16:25
Documents
1
Period of Report
2017-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_149090857141894.html 4  
1 FORM 4 wf-form4_149090857141894.xml 4 3584
  Complete submission text file 0001274644-17-000023.txt   5098
Mailing Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94063
Business Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94063 650-475-0158
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O OCERA THERAPEUTICS, INC. 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Byrnes Michael (Reporting) CIK: 0001619893 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 17726869